Popular on Rezul
- Innovative Airbnb Realtor Specialization Program Launches
- Former DEI Officer Poised to Resume Work in Civil Rights Space After Addressing False Allegations
- Holly Fraccaro Named National Association of Home Builders 2022 Executive of the Year
- Screening for the Best Residents
- Transforming Lives Globally: Rapid Transformational Therapy Helps Clients Worldwide Overcome Anxiety and Depression
- New York Notary Signing Services Leads the Way in State Apostille and Authentication Services
- Colliers brokers sale of two outparcels in Richmond shopping center for a total of $5.38M
- StackSource Surpasses $1.5 Billion in Commercial Real Estate Transactions
- Central Florida's Leading Realtor, Bent Danholm, Announces 27-Day Home Sale Guarantee or Pays Up To $ 10,000
- Richard Crenian - Multi Tenant Commercial Real Estate is Changing Everything
Similar on Rezul
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- Autonomous eVTOLs $25 Billion Market by 2030
- Material Capital Partners Completes Exit of The Preserve at Sweetwater, Expands BFR Pipeline in the Southeast
- North Carolina Entrepreneur Awarded 2023 Small Business Advocate of the Year By NSBA
- Customer Agility Framework™ soft launch
- Sparkling Logic Launching Generative AI-Powered Tool for Decision Management
- 5 Steps to an Exceptional Presentation
- SHO-TEK Expands Nationwide PMO Consulting Services; Launches Free PMO Assessment Tools
- Pizza Hut Joins Colony Ridge Communities, Amplifying the Neighborhood's Vibrant Offerings!
- Namify's Innovative Organization Name Generator Redefines Branding
Elevance Health's 2.750% Senior Convertible Debentures due 2042 to Accrue Contingent Interest
Rezul News/10615937
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the "Debentures") will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a Debenture for the ten consecutive trading days ended October 14, 2022. Contingent interest, which the Company has determined to be approximately $16.8123 per Note, will be payable on April 15, 2023 to holders of the Debentures as of the April 1, 2023 record date.
About Elevance Health, Inc.
Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health's companies serve more than 119 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.
Forward-Looking Statements
This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not undertake to update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and other catastrophes; the impact of new or changes in existing federal, state and international laws or regulations, including healthcare laws and regulations, or their enforcement or application; the impact of cyber-attacks or other privacy or data security incidents or breaches or our failure to comply with any privacy or security laws or regulations, including any investigations, claims or litigation related thereto; information technology disruptions; changes in economic and market conditions, as well as regulations that may negatively affect our liquidity and investment portfolios; competitive pressures and our ability to adapt to changes in the industry and develop and implement strategic growth opportunities; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon; our ability to maintain and achieve improvement in Centers for Medicare and Medicaid Services Star ratings and other quality scores and funding risks with respect to revenue received from participation therein; a negative change in our healthcare product mix; costs and other liabilities associated with litigation, government investigations, audits or reviews; our ability to contract with providers on cost-effective and competitive terms; failure to effectively maintain and modernize our information systems; risks associated with providing pharmacy benefit management ("PBM"), healthcare and other diversified products and services, including medical malpractice or professional liability claims and non-compliance by any party with the PBM services agreement between us and CaremarkPCS Health, L.L.C.; risks associated with mergers, acquisitions, joint ventures and strategic alliances; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness and the risk that increased interest rates or market volatility could impact our access to or further increase the cost of financing; a downgrade in our financial strength ratings; the effects of any negative publicity related to the health benefits industry in general or us in particular; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.
More on Rezul News
Contacts
Media Contact:
Leslie Porras
Leslie.Porras@elevancehealth.com
Investor Relations:
Stephen Tanal
Stephen.Tanal@elevancehealth.com
About Elevance Health, Inc.
Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health's companies serve more than 119 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.
Forward-Looking Statements
This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not undertake to update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and other catastrophes; the impact of new or changes in existing federal, state and international laws or regulations, including healthcare laws and regulations, or their enforcement or application; the impact of cyber-attacks or other privacy or data security incidents or breaches or our failure to comply with any privacy or security laws or regulations, including any investigations, claims or litigation related thereto; information technology disruptions; changes in economic and market conditions, as well as regulations that may negatively affect our liquidity and investment portfolios; competitive pressures and our ability to adapt to changes in the industry and develop and implement strategic growth opportunities; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon; our ability to maintain and achieve improvement in Centers for Medicare and Medicaid Services Star ratings and other quality scores and funding risks with respect to revenue received from participation therein; a negative change in our healthcare product mix; costs and other liabilities associated with litigation, government investigations, audits or reviews; our ability to contract with providers on cost-effective and competitive terms; failure to effectively maintain and modernize our information systems; risks associated with providing pharmacy benefit management ("PBM"), healthcare and other diversified products and services, including medical malpractice or professional liability claims and non-compliance by any party with the PBM services agreement between us and CaremarkPCS Health, L.L.C.; risks associated with mergers, acquisitions, joint ventures and strategic alliances; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness and the risk that increased interest rates or market volatility could impact our access to or further increase the cost of financing; a downgrade in our financial strength ratings; the effects of any negative publicity related to the health benefits industry in general or us in particular; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.
More on Rezul News
- GreenPointe expanding Community Amenities at TrailMark
- Rhody Rug Revolutionizes Online Shopping Experience with the Launch of their New Direct-to-Consumer Website
- Long Island businessman turned recording artist, John Beyer, to release his first love song aptly titled, …"Love You More"
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- Exploring the World of Web3? Lympid Puts Users Front and Center
Contacts
Media Contact:
Leslie Porras
Leslie.Porras@elevancehealth.com
Investor Relations:
Stephen Tanal
Stephen.Tanal@elevancehealth.com
Filed Under: Business
0 Comments
Latest on Rezul News
- Patton Acquires Tone Commander
- Customer Agility Framework™ soft launch
- New Kickstarter Campaign - 7 Exclusive Novels from Ray Keating
- Moolwan releases 10 new Home Decor Items to help customers decorate their homes into opulent masterpieces
- City of Fairfax triples access to public restrooms with innovative high tech solution
- Big Developments Unveiled as Twist Technology Announces Leadership Changes and Booming Growth
- Toll Brothers Purchases 40 Single-Family Detached Lots within Palm Springs MPC Escena
- Sparkling Logic Launching Generative AI-Powered Tool for Decision Management
- 5 Steps to an Exceptional Presentation
- Guardian secures 71,645 square foot industrial space at The Mill at 249
- SHO-TEK Expands Nationwide PMO Consulting Services; Launches Free PMO Assessment Tools
- Axiros ACS solution enables Earth Broadband to manage multiple client devices and CPE on AX69
- Art Exhibition - David Mackenzie: Outside the Lines
- Denville Real Estate Broker Promotes Luxury Home To MORE Buyers For MORE Money
- Private Offices, Virtual Offices & Meeting Room in Calgary Alberta
- Suleman: A Pinnacle of Excellence in Real Estate- Celebrating Over 13 Years of Award-Winning Success
- Pizza Hut Joins Colony Ridge Communities, Amplifying the Neighborhood's Vibrant Offerings!
- Desert Outdoor Lighting Announces a 10% Discount for the Beginning of the Holiday Lighting Season
- Colliers finalizes sale/leaseback of industrial investment sites leased to Knight Energy
- Mountain Fresh Water Systems Announces 5% End-of-Summer Discount on All Services